Showing 6,012 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

Biktarvy Effective in Those With Adherence Challenges

Editor's pick
Infectious Disease Special Edition
30 November 2023
Cardiovascular disease

UK experts recommend statins for all people with HIV aged 40 and over

News
23 November 2023
Retention & linkage to care

Systemic Global Review Reports High Prevalence of Delayed HIV Treatment Initiation

Editor's pick
TheBodyPro
21 November 2023
PrEP programmes & uptake

Is on-demand PrEP too demanding? Australian men’s experiences

News
17 November 2023
Weight gain & lipodystrophy

New weight-loss drugs appear safe and effective for people living with HIV

News
16 November 2023
Injectable & long-acting HIV treatment

In-depth: How do long-acting HIV treatments work?

Editor's pick
Spotlight
14 November 2023
Retention & linkage to care

Non-Compliance Isn't the Issue. Systemic Racism Prevents Access to HIV Prevention and Care

Editor's pick
TheBodyPro
13 November 2023
Cardiovascular disease

More evidence that integrase inhibitors don’t raise heart disease risk

News
10 November 2023
Access to healthcare

Patients, doctors, advocates launch campaign to press for increased use of injectable HIV medication in British Columbia

Editor's pick
CBC
8 November 2023
Adherence

In Kenya, emotional violence, mental health found as key obstacles to lifesaving HIV treatments for young females

Editor's pick
Medical Xpress
8 November 2023
Bad science & bogus treatments

CRISPR gene therapy appears safe, but claims of an imminent HIV cure are premature

News
3 November 2023
Ageing & HIV

aidsmapLIVE: HIV and ageing Video

November 2023
HIV treatment

Dolutegravir-Based ART — Effective for HIV-2 Infection

Editor's pick
AfroCAB
31 October 2023
HIV treatment

2023 HIV Market Report: The state of HIV market in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
31 October 2023
Weight gain & lipodystrophy

GLP-1 receptor agonists promote weight loss among people with HIV One Quarter of PWH Lose More Than 5% of Weight With GLP-1 Agonists

Editor's pick
NATAP
27 October 2023
Hepatitis B

HBcAb positivity is a risk factor for failure to achieve complete virologic suppression of HIV-RNA after antiretroviral switch to 3TC+DTG

Editor's pick
NATAP
27 October 2023
Changing treatment

One Third of French Group Has Not Changed Antiretrovirals for Over 10 Years

Editor's pick
NATAP
27 October 2023
Injectable & long-acting HIV treatment

Long-acting injectable treatment highly effective in European cohort studies

News
26 October 2023
Injectable & long-acting HIV treatment

Cabotegravir/Rilpivirine Injections Administered During Home Health Visit Show Promise in Pilot Study

Editor's pick
TheBodyPro
26 October 2023
Injectable & long-acting HIV treatment

ViiV Healthcare receives approval from China’s national medical products administration for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine)

Editor's pick
ViiV press release
26 October 2023
People & personal stories

From HIV to obesity – Professor Francois Venter on fighting for better health for more people

Editor's pick
Daily Maverick
25 October 2023
Mental & emotional health & wellbeing

PrEP Adherence and Depression Screening in LGBTQ+ Communities

Editor's pick
Infectious Disease Advisor
24 October 2023
Economic & social inequality

10 Charged in $20 Million Scheme to Sell Black-Market HIV Drugs

Editor's pick
The New York Times
23 October 2023
Weight gain & lipodystrophy

Body mass index is sufficient to predict diabetes or metabolic syndrome, Italian study finds

News
23 October 2023